Australian medical technology company QHeart Medical has received conditional Human Research Ethics Committee approval.
Neurotech International has received Human Research Ethics Committee approval to start a phase III clinical study, evaluating ...
KELOWNA, BC / ACCESS Newswire / February 24, 2025 / Lexaria Bioscience Corp. (LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces it has received ...
Bryet US Inc. has received Australian Human Research Ethics Committee (HREC) approval for its first-in-human study of ML-016 for patients with advanced cancer with lung and/or liver involvement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results